The market performance of Poseida Therapeutics Inc’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $4.27 on 03/01/24, while the lowest value for the same duration was $1.54 on 06/29/23.
52-week price history of PSTX Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Poseida Therapeutics Inc’s current trading price is -35.13% away from its 52-week high, while its distance from the 52-week low is 79.87%. The stock’s price range during the 52-week period has remained between $1.54 and $4.27. In the Healthcare sector, the company’s shares saw a trading volume of around 2.86 million for the day, which was evidently higher than the average daily volume of 0.72 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Poseida Therapeutics Inc (PSTX) has experienced a quarterly decline of -19.48% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 268.50M and boasts a workforce of 330 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.13, with a change in price of -0.29. Similarly, Poseida Therapeutics Inc recorded 906,138 in trading volume during the last 100 days, posting a change of -9.48%.
Examining PSTX’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for PSTX stands at 0.82. Similarly, the long-term debt-to-equity ratio is also 0.77.
PSTX Stock Stochastic Average
As of today, Poseida Therapeutics Inc’s raw stochastic average for the last 50 days stands at 37.50%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 66.67%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 46.91% and 32.83%, respectively.
PSTX Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Until today this year the stock’s price performance recorded a decrease of -17.56%. However, over the last six months, the performance has been weaker by 36.45%. The price of PSTX decreased -4.48% over the last 30 days. And in the last five days, it has surged by 33.82%.
